PI
AMAG

PineBridge Investments’s AMAG Pharmaceuticals AMAG Stock Holding History

PineBridge Investments’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-6,065
Closed -$70K – 1213
2019
Q3 		$70K Buy
6,065
+2,313
+62% +$24.3K ﹤0.01% 996
2019
Q2 		$37K Sell
3,752
-46,002
-92% -$496K ﹤0.01% 965
2019
Q1 		$640K Buy
49,754
+8,169
+20% +$122K 0.01% 649
2018
Q4 		$632K Sell
41,585
-15,885
-28% -$303K 0.01% 628
2018
Q3 		$1.15M Buy
57,470
+2,390
+4% +$54.4K 0.02% 559
2018
Q2 		$1.07M Sell
55,080
-14,116
-20% -$312K 0.03% 586
2018
Q1 		$1.39M Buy
+69,196
New +$1.17M 0.03% 502
2017
Q4 		– Sell
-4,380
Closed -$81K – 1177
2017
Q3 		$81K Sell
4,380
-238
-5% -$4.44K ﹤0.01% 983
2017
Q2 		$85K Sell
4,618
-18,660
-80% -$370K ﹤0.01% 953
2017
Q1 		$525K Buy
23,278
+6,820
+41% +$163K 0.01% 643
2016
Q4 		$573K Buy
16,458
+12,116
+279% +$362K 0.02% 598
2016
Q3 		$106K Buy
4,342
+97
+2% +$2.42K ﹤0.01% 764
2016
Q2 		$101K Hold
4,245
– – 0.01% 760
2016
Q1 		$99K Buy
+4,245
New +$101K 0.01% 730

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

PineBridge Investments's AMAG Position: Q4 2019 in Review

PineBridge Investments sold out of AMAG Pharmaceuticals (AMAG) in Q4 2019, closing a stake of 6,065 shares — an estimated $70K sold.

PineBridge Investments first reported a position in AMAG in Q1 2016 and held it in 14 quarters. The position peaked at $1.39M in Q1 2018. 134 funds tracked by Wall St. Rank hold AMAG as of Q4 2019.

  • PineBridge Investments reported no remaining AMAG Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • PineBridge Investments sold 6,065 AMAG Pharmaceuticals shares in Q4 2019, an estimated $70K.
  • PineBridge Investments first reported a position in AMAG Pharmaceuticals in Q1 2016 and held it in 14 quarters.
  • PineBridge Investments's AMAG Pharmaceuticals position peaked at $1.39M in Q1 2018.
  • 134 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2019.

Based on PineBridge Investments's 13F filing for Q4 2019, filed 13 Feb 2020.